Molina Healthcare is a managed care organization that provides health insurance services primarily to individuals and families participating in government programs such as Medicaid and Medicare. The company focuses on delivering coordinated care and comprehensive health services, emphasizing preventive care management to improve patient outcomes. Molina Healthcare operates in various states across the United States, offering a range of plans tailored to meet the needs of diverse populations, including those with chronic illnesses or complex health conditions. With a commitment to community engagement and quality health care, Molina aims to ensure that its members have access to affordable health services and support. Read More
Shares of healthcare insurance company Molina Healthcare (NYSE:MOH)
fell 6.7% in the morning session after the company reported weak first-quarter 2025 results, missing analysts' expectations on EBITDA despite beating on revenue, EPS, and membership growth. Medical costs ticked up as expected, and EBITDA performance was softer than anticipated. The medical care ratio rose to 89.2%, as higher utilization in long-term care and behavioral health pushed costs above forecast, especially in the Medicaid and Marketplace segments. Overall, the results disappointed.
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade tensions boosts risk sentiment.
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Healthcare insurance company Molina Healthcare (NYSE:MOH) announced better-than-expected revenue in Q1 CY2025, with sales up 12.2% year on year to $11.15 billion. Its non-GAAP profit of $6.08 per share was 2.1% above analysts’ consensus estimates.
Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported first quarter 2025 GAAP earnings per diluted share of $5.45 and adjusted earnings per diluted share of $6.08. Financial results are summarized below:
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence.
A number of stocks fell in the afternoon session after President Trump criticized the Federal Reserve's approach to interest rate cuts, warning that the pace was slow and could hinder economic growth. Trump's comments added pressure to an already sensitive market, raising concerns about political interference in monetary policy.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.
Wall Street gained ground by midday trading on Tuesday, as investor concerns over the economic impact of trade tensions continued to ease following recent signs that the Trump administration was taking a more conciliatory approach.
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Let’s dig into the relative performance of Humana (NYSE:HUM) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.
